General Information of Drug (ID:
DR5866) |
Drug Name |
Lestaurtinib
|
Synonyms |
A 1544750; CEP 701; KT 5555; KT5555; SP 924; CEP-701; KT-5555; SPM-924; Lestaurtinib (USAN/INN) |
Indication |
Acute lymphoblastic leukemia
[ICD11: 2B33]
|
Phase 3
|
[1]
|
Psoriasis vulgaris
[ICD11:
ICD11: EA90]
|
Phase 2/3
|
[2]
|
Acute myeloid leukaemia
[ICD11:
ICD11: 2A60]
|
Phase 2
|
[3]
|
Structure |
|
|
3D MOL
|
2D MOL
|
Pharmaceutical Properties |
Molecular Weight |
439.5 |
Topological Polar Surface Area |
88.6 |
Heavy Atom Count |
33 |
Rotatable Bond Count |
1 |
Hydrogen Bond Donor Count |
3 |
Hydrogen Bond Acceptor Count |
4 |
Cross-matching ID |
- PubChem CID
- 126565
- ChEBI ID
-
- CAS Number
-
- TTD Drug ID
- D0V9WF
- Formula
- C26H21N3O4
- Canonical SMILES
- C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(CO)O
- InChI
- InChI=1S/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18-,25+,26+/m1/s1
- InChIKey
- UIARLYUEJFELEN-LROUJFHJSA-N
|
|
|
|
|
|
|
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.